Covid19-Sources

Von den 919.731 Personen, die im Rahmen der Studie auf COVID-19 getestet wurden, stellten die Forscher fest, dass die 43.375 positiv getesteten Personen ein 3,5-mal erhöhtes Risiko hatten, mit Alzheimer diagnostiziert zu werden, 2,6-mal mit Parkinson, 2,7-mal mit ischämischem Schlaganfall und a 4,8-mal erhöht mit intrazerebraler Blutung (Blutung im Gehirn). Während Neuroinflammation zu einer beschleunigten Entwicklung neurodegenerativer Erkrankungen beitragen kann, hoben die Autoren auch die Auswirkungen des wissenschaftlichen Fokus auf Langzeitfolgen nach COVID-19 hervor.

The constellation of findings show that reinfection adds non-trivial risks of all-cause mortality, hospitalization, and adverse health outcomes in the acute and post-acute phase of the reinfection. Reducing overall burden of death and disease due to SARS-CoV-2 will require strategies for reinfection prevention.

We show that compared to people with first infection, reinfection contributes additional risks of all-cause mortality, hospitalization, and adverse health outcomes in the pulmonary and several extrapulmonary organ systems (cardiovascular disorders, coagulation and hematologic disorders, diabetes, fatigue, gastrointestinal disorders, kidney disorders, mental health disorders, musculoskeletal disorders, and neurologic disorders); the risks were evident in those who were unvaccinated, had 1 shot, or 2 or more shots prior to the second infection; the risks were most pronounced in the acute phase, but persisted in the post-acute phase of reinfection, and most were still evident at 6 months after reinfection.